Last news
Messenger Biopharma licenses its Nuntius biotechnology to mRNA players
posted October 28, 2024
Find us
Messenger Biopharma is perfecting a biotechnology of in vivo mRNA transfection, which has been patented. This biotechnology tends to optimize the process of mRNA delivery to mammalian cells, as well as the mRNA sequence.
News
Messenger Biopharma licenses its Nuntius biotechnology to mRNA players
October 28, 2024
OST Group becomes a shareholder in July 2019
July 08, 2019